Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Kozlitina, Julia, Smagris, Eriks, Stender, Stefan, Nordestgaard, Børge G, Zhou, Heather H, Tybjærg-Hansen, Anne, Vogt, Thomas F, Hobbs, Helen H +1 more·2014·Nature Genetics

DOI 10.1038/ng.2901

Cited by (1,001)

Items 301–400 of 1,001

The Copenhagen City Heart Study (Østerbroundersøgelsen)
Yasmine Aguib, Jassim M. S. Al Suwaidi · 2015 · Global Cardiology Science and Practice
HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit
Gabrielle Vièyres, Thomas Pietschmann · 2019 · Cells
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases
Ethan M. Weinberg, Huy Ngoc Trinh, Roberto J. Firpi, Kalyan Ram Bhamidimarri, Samuel Klein, Jonathan Durlam, Stephanie E. Watkins, K. Rajender Reddy, Michael Weiss, Richard C. Zink et al. · 2020 · Clinical Gastroenterology and Hepatology
17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury
Yanling Ma, Philip M. Brown, Dennis D. Lin, Jing Ma, Dechun Feng, Olga V. Belyaeva, Maren Catherina Podszun, Jason Roszik, Joselyn Natasha Allen, Regina Umarova et al. · 2020 · Hepatology
A “systems medicine” approach to the study of non-alcoholic fatty liver disease
Salvatore Petta, Luca V. C. Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Carmela Loguercio, Amedeo Lonardo, Fabio Marra et al. · 2015 · Digestive and Liver Disease
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
Daniel Ferraz de Campos Mazo, Fernanda de Mello Malta, José Tadeu Stefano, Ana Paula Moreira Salles, Michele Soares Gomes‐Gouvêa, Ana Catharina de Seixas Santos Nastri, Jazon Romilson Souza Almeida, João Renato Rebello Pinho, Flair José Carrilho, Claudia Pinto Marques Souza de Oliveira · 2019 · Annals of Hepatology
Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
Botao Li, Ming Sun, Yunfeng Li, Ju-Qiong Wang, Zi-Mu Zhou, Bao‐Liang Song, Jie Luo · 2020 · PLoS Genetics
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
Olfa Khalifa, Khaoula Errafii‬, Nayla S. Al-Akl, Abdelilah Arredouani · 2020 · Disease Markers
TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease
Sanchez-Pulido, Luis, Ponting, Chris P. · 2014 · Frontiers in Genetics
Nuclear envelope–localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis
Ji‐Yeon Shin, Antonio Hernández‐Ono, Tatyana V. Fedotova, Cecilia Östlund, Michael J. Lee, Sarah B. Gibeley, Chun-Chi Liang, William T. Dauer, Henry N. Ginsberg, Howard J. Worman · 2019 · Journal of Clinical Investigation
Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling
Mingfeng Xia, Hailuan Zeng, Sijia Wang, Huiru Tang, Xin Gao · 2020 · Journal of Hepatology
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, Arturo Santos, Juan Armendáriz‐Borunda · 2022 · Cancers
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics
Melania Manco · 2017 · Children
Nonalcoholic Fatty Liver Disease: A Global Perspective
Wei‐Kei Wong, Wah‐Kheong Chan · 2021 · Clinical Therapeutics
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD
Maral Amangurbanova, Daniel Q. Huang, Rohit Seth Loomba · 2022 · Alimentary Pharmacology & Therapeutics
GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms
Lucas D. Ward, Ho-Chou Tu, Chelsea B. Quenneville, Shira Tsour, Alexander O. Flynn-Carroll, Margaret M. Parker, Aimée M. Deaton, Patrick A. J. Haslett, Luca A. Lotta, Niek Verweij et al. · 2021 · Nature Communications
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
Xia, Mingfeng, Chandrasekaran, Preethi, Rong, Shunxing, Fu, Xiaorong, Mitsche, Matthew A. · 2021 · Journal of Lipid Research
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
Aamir Bashir, Ajay Kumar. Duseja, Arka De, Manu Mehta, Pramil Tiwari · 2022 · Liver Research
Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
Nicole Ehrhardt, Michael E. Doche, Shuang Chen, Hui Z. Mao, Meghan T. Walsh, Candy Bedoya, Maha M. Guindi, Weidong Xiong, Joseph Ignatius Irudayam, Jahangir Iqbal et al. · 2017 · Human Molecular Genetics
Insights into the Role of PPARβ/δ in NAFLD
Jiapeng Chen, Alexandra Montagner, Nguan Soon Tan, Walter Wahli · 2018 · International Journal of Molecular Sciences
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
Jee‐Fu Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, Chung‐Feng Huang, Ching‐I Huang, Meng‐Hsuan Hsieh, Chia‐Yen Dai, Jeng‐Fu Yang, Shinn‐Cherng Chen, Ming‐Lung Yu et al. · 2019 · Journal of the Formosan Medical Association
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients
Marta Milano, Alessio Aghemo, Rosellina Margherita Mancina, Janett Fischer, Paola Dongiovanni, Stella De Nicola, Anna Ludovica Fracanzani, Roberta D’Ambrosio, Marco Maggioni, Raffaele De Francesco et al. · 2015 · Hepatology
Cholesterol Transport Revisited: A New Turbo Mechanism to Drive Cholesterol Excretion
Jan Freark de Boer, Folkert Kuipers, Albert Kornelis Groen · 2017 · Trends in Endocrinology and Metabolism
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis
J. Bernadette Moore · 2019 · Proceedings of The Nutrition Society
Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah‐Kheong Chan · 2022 · Clinical and Molecular Hepatology
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato · 2023 · Biomedicines
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Le Zhang, Mortada H.F. El-Shabrawi, Louise Alison Baur, Christopher D. Byrne, Giovanni Targher, Mohit Kehar, Gilda Porta, Way Seah Lee, Sander Lefere, Serap Turan et al. · 2024 · Med
Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns
Daniel Seung Kim, Anne U. Jackson, Yatong K. Li, Heather M. Stringham, Johanna Kuusisto, Antti J. Kangas, Pasi Soininen, Mika Ala‐Korpela, Charles Burant, Veikko V Salomaa et al. · 2017 · Journal of Lipid Research
Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
Ivica Grgurević, Tonći Božin, Mislav Mikuš, Michał Kukla, James P. O’Beirne · 2021 · Cancers
Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
Xiao-Ying Liu, Anne S. Henkel, Brian E. LeCuyer, M. Schipma, K. Anderson, R. Green · 2015 · American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease
Serena Pelusi, Luca V. C. Valenti · 2018 · Liver International
Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis
Ye Tian, Matthew J. Jellinek, Kritika Mehta, Sun Mi Seok, Shanny Hsuan Kuo, Wei Lu, Ruicheng Shi, Richard G. Lee, Gee W. Lau, Jongsook Kim Kemper et al. · 2023 · Hepatology
Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
Manoj Amrutkar, Matthias Kern, Esther Nuñez‐Durán, Marcus Ståhlman, Emmelie Cansby, Urszula Chursa, Elin Stenfeldt, Jan Borén, Matthias Blüher, Margit Mahlapuu · 2015 · Diabetologia
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients
Paola Dongiovanni, Marica Meroni, Guido Baselli, Rosellina Margherita Mancina, Massimiliano Ruscica, Miriam Longo, Raffaela Rametta, Annalisa Cespiati, Serena Pelusi, Nicola Ferri et al. · 2019 · Journal of Lipid Research
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives
Grazia Pennisi, Ciro Celsa, Antonina Giammanco, Federica Spatola, Salvatore Petta · 2019 · International Journal of Molecular Sciences
Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study
Jianbo Tian, Rong Zhong, Cheng Liu, Yuhan Tang, Jing Gong, Jiang Chang, Jiao Lou, Juntao Ke, Jiaoyuan Li, Yi Zhang et al. · 2016 · Scientific Reports
Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease
Silvia C. Sookoian, Diego Martin Flichman, Martin E. Garaycoechea, Carla Gazzi, Julio San Martino, Gustavo Osvaldo Castaño, Carlos Jose Pirola · 2018 · Scientific Reports
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Daniela Stols‐Gonçalves, Luca Schiliró Tristão, Peter Henneman, Max Nieuwdorp · 2019 · Current Diabetes Reports
Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD
Viera Kupčová, Michaela Fedelešová, J Bulas, Petra Kozmonová, Ladislav Turecký · 2019 · International Journal of Environmental Research and Public Health
TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
Viktorija Basytė-Bacevičė, Jurgita Skiecevičienė, Irena Valantienė, Jolanta Šumskienė, Vitalija Petrenkienė, Jūratė Kondrackienė, Dalius Petrauskas, Frank Lammert, Juozas Kupčinskas · 2019 · International Journal of Molecular Sciences
PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD
Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta, Fabio Marra, Rosellina Margherita Mancina, Jussi Pihlajamäki, Dorota Kakol‐Palm, Anne‐Christine Andréasson, Paola Dongiovanni, Anna Ludovica Fracanzani et al. · 2020 · Liver International
Diabetes as a risk factor for MASH progression
Sofiya Gancheva, Michael Roden, Laurent Castéra · 2024 · Diabetes Research and Clinical Practice
TM 6 SF 2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA 3 polymorphism
Nicola Coppola, Rosa Zampino, Grazia Cirillo, Maria Stanzione, Margherita Macera, Adriana Boemio, Anna Grandone, Mariantonietta Pisaturo, Aldo Marrone, Luigi Elio Adinolfi et al. · 2015 · Liver International
Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease
Bratati Kahali, Brian D. Halligan, Elizabeth K. Speliotes · 2015 · Seminars in Liver Disease
Association of MBOAT7 gene variant with plasma ALT levels in children: the PANIC study
Anna Viitasalo, Aino‐Maija Eloranta, Mustafa Atalay, Stefano Romeo, Jussi Pihlajamäki, Timo Antero Lakka · 2016 · Pediatric Research
The genetic backgrounds in nonalcoholic fatty liver disease
Yuya Seko, Kanji Yamaguchi, Yoshito Itoh · 2018 · Clinical Journal of Gastroenterology
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Stephan Buch, Hamish A. Innes, Philipp Ludwig Lutz, Hans Dieter Nischalke, Jens Uwe Marquardt, Janett Fischer, Karl Heinz Weiss, Jonas Rosendahl, Astrid Marot, Marcin Jan Krawczyk et al. · 2022 · Gut
Human-based systems: Mechanistic NASH modelling just around the corner?
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Marcelino Rodrigues · 2018 · Pharmacological Research
Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
Martijn C.G.J. Brouwers, Nynke Simons, Coen D.A. Stehouwer, Ger H. Koek, Nicolaas C. Schaper, Aaron J. Isaacs · 2019 · Hepatology Communications
Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes
Wasco Wruck, Karl Kashofer, Samrina Rehman, Andriani Daskalaki, Daniela Berg, Ewa Gralka, Justyna Józefczuk, Katharina Drews, Vikash Pandey, Christian R. A. Regenbrecht et al. · 2015 · Scientific Data
Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease
Hagström, Hannes, Kechagias, Stergios, Ekstedt, Mattias · 2022 · Journal of Internal Medicine
A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients
Eslam, Mohammed, Wong, Grace Lai-Hung, Hashem, Ahmed M., Chan, Henry Lik-Yuen, Nielsen, Mette Juul, Leeming, Diana Julie, Chan, Anthony Wing-Hung, Chen, Yu, Duffin, Kevin L., Karsdal, Morten et al. · 2021 · American Journal of Gastroenterology
Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort
Jun Wang, David V. Conti, David Daniel Bogumil, Xin Sheng, Mazen Noureddin, Lynne Ross Wilkens, Loı̈c Le Marchand, Hugo R. Rosen, Christopher A. Haiman, Veronica Wendy Setiawan · 2021 · Hepatology Communications
Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review
Xiaolin Li, Jian-Qing Sui, Linlin Lu, Nannan Zhang, Xin Yi Xu, Quanyong Dong, Yongning Xin, Shiying Xuan · 2016 · Lipids in Health and Disease
The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C
Caroline Manchiero, Arielle Karen da Silva Nunes, Mariana Cavalheiro Magri, Bianca Peixoto Dantas, Celso Carmo Mazza, Antônio Alci Barone, Fátima Mitiko Tengan · 2017 · BMC Infectious Diseases
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
Bérénice Charrez · 2016 · World Journal of Gastroenterology
TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD
Giovanni Musso, Ugo Cipolla, Maurizio Cassader, Silvia Pinach, Francesca Saba, Franco De Michieli, Elena Paschetta, Daria Bongiovanni, Luciana Framarin, Nicola Leone et al. · 2017 · Journal of Lipid Research
Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad · 2021 · Biomedicines
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
Mazen Noureddin, Quentin Mark Anstee, Rohit Seth Loomba · 2016 · Alimentary Pharmacology & Therapeutics
Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma
Maneerat Raksayot, Natthaya Chuaypen, Apichaya Khlaiphuengsin, Nutcha Pinjaroen, Sombat Treeprasertsuk, Yong Poovorawan, Yasuhito Tanaka, Pisit Tangkijvanich · 2018 · Journal of Gastroenterology
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
Kahealani Uehara, Jaimarie Sostre‐Colón, Matthew J. Gavin, Dominic Santoleri, Kelly‐Ann Leonard, René L. Jacobs, Paul M. Titchenell · 2022 · Cellular and Molecular Gastroenterology and Hepatology
Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease
Wasco Wruck, Nina Graffmann, Marie-Ann Kawala, James Adjaye · 2016 · Stem Cells
Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Salvatore Petta, Luca V. C. Valenti, Gianluca Svegliati‐Baroni, Massimiliano Ruscica, Rosaria Maria Pipitone, Paola Dongiovanni, Chiara Rychlicki, Nicola Ferri, Calogero Cammà, Anna Ludovica Fracanzani et al. · 2017 · The Journal of Clinical Endocrinology & Metabolism
The role of IFN in the development of NAFLD and NASH
Michelle Møhlenberg, Ewa Terczyńska‐Dyla, Karen Louise Thomsen, Jacob George, Mohammed Eslam, Henning Grønbæk, Rune Hartmann · 2018 · Cytokine
Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis
Shan Tang, Jing Zhang, Tingting Mei, Hai-Qing Guo, Xinhuan Wei, Wenyan Zhang, Yali Liu, Shan Liang, Zuo-Peng Fan, Lixia Ma et al. · 2019 · BMC Cancer
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, Luca V. C. Valenti · 2021 · JHEP Reports
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, Kahealani, Santoleri, Dominic, Whitlock, Anna E. Garcia, Titchenell, Paul M. · 2023 · Comprehensive Physiology
The influence of host genetics on liver microbiome composition in patients with NAFLD
Carlos Jose Pirola, Adrián Salatino, Maria Florencia Quintanilla, Gustavo Osvaldo Castaño, Martin E. Garaycoechea, Silvia C. Sookoian · 2022 · EBioMedicine
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
Amedeo Lonardo, Ashwani Kumar Singal, Natalia A. Osna, Kusum K. Kharbanda · 2022 · Metabolism and Target Organ Damage
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel · 2024 · Cancers
The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese
Xiaoliang Wang, Zhipeng Liu, Zhihai Peng, Wanqing Liu · 2015 · Journal of Hepatology
Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice
J Berger, Angel Loza‐Valdes, Jesper Gromada, Norma N. Anderson, Jay D. Horton · 2017 · Journal of Lipid Research
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
Nicholas Chew, Bryan Chong, Cheng Han Ng, Gwyneth Kong, Yip Han Chin, Wang Xiao, Chang Jie Mick Lee, Yock Young Dan, Mark Dhinesh Muthiah, Roger Foo · 2022 · Frontiers in Genetics
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
Paulina Głuszyńska, Dorota Lemancewicz, Janusz Bogdan Dzięcioł, Hady Razak Hady · 2021 · Journal of Clinical Medicine
Shared Mechanisms between Cardiovascular Disease and NAFLD
Daniel Q. Huang, Michael Downes, Ronald M. Evans, Joseph Lee Witztum, Christopher K. Glass, Rohit Seth Loomba · 2022 · Seminars in Liver Disease
Update on genetics and epigenetics in metabolic associated fatty liver disease
Xiaopeng Zhu, Mingfeng Xia, Xin Gao · 2022 · Therapeutic Advances in Endocrinology and Metabolism
Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease
Haoxuan Zou, Xiaopu Ma, Fan Zhang, Yan Xie · 2023 · Lipids in Health and Disease
The Membrane‐bound O‐Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease
Anna Di Sessa, Giuseppina Rosaria Umano, Grazia Cirillo, Angela Del Prete, Roberta Iacomino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice · 2018 · Journal of Pediatric Gastroenterology and Nutrition
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Sana Raza, Sangam Rajak, Baby Anjum, Rohit A. Sinha · 2019 · Hepatoma Research
Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation
Kristin Schwerbel, Anne Kamitz, Natalie Krahmer, Nicole Hallahan, Markus Jähnert, Pascal Gottmann, Sandra Lebek, Tanja Schallschmidt, Danny Arends, Fabian Schumacher et al. · 2020 · Journal of Hepatology
Perspectives on youth‐onset nonalcoholic fatty liver disease
Eduardo Castillo‐Leon, Catherine E. Cioffi, Miriam B. Vos · 2020 · Endocrinology Diabetes & Metabolism
Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis
Silvia C. Sookoian, Carlos Jose Pirola · 2016 · Hepatology
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
Katherine Martin, Anas Hatab, Varinder Singh Athwal, Elliot J. Jokl, Karen Piper Hanley · 2021 · Current Diabetes Reports
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
Umberto Vespasiani Gentilucci, Paolo Gallo, Chiara Dell’Unto, Mara Volpentesta, Raffaele Antonelli Incalzi, Antonio Picardi · 2018 · World Journal of Gastroenterology
High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population
Maricruz Sepúlveda-Villegas, Sonia Román, Ingrid Rivera‐Íñiguez, Claudia Ojeda‐Granados, Karina González-Aldaco, Luis Alberto Torres-Reyes, Alexis José-Ábrego, Arturo Panduro · 2019 · PLoS ONE
Relationship between non-alcoholic fatty liver disease and coronary heart disease
Uğur Arslan, Mustafa Yenerçağ · 2020 · World Journal of Clinical Cases
Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki et al. · 2016 · BMC Gastroenterology
Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics
Pierluigi Marzuillo · 2015 · World Journal of Hepatology
Non-alcoholic fatty liver disease: a narrative review of genetics
J. Christopher, Yao Zemin, Zhenghui Gordon Jiang · 2018 · Journal of Biomedical Research
Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Rosa Lombardi, Federica Iuculano, Giada Pallini, Silvia Rossana Fargion, Anna Ludovica Fracanzani · 2020 · International Journal of Molecular Sciences
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity
Partha Pal, Rajan Palui, Sayantan Ray · 2021 · World Journal of Hepatology
Contribution of a genetic risk score to ethnic differences in fatty liver disease
Maddie J. Kubiliun, Jonathan C. Cohen, Helen H. Hobbs, Julia Kozlitina · 2022 · Liver International
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Lingzhi Chen, Annapurna Kuppa, Antonino Oliveri, Yanhua Chen, Prabhu Ponnandy, Puja B. Patel, Nicholette D. Palmer, Elizabeth K. Speliotes · 2025 · Journal of Clinical Investigation
The UCP 2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
Roberta Fares, Salvatore Petta, Rosa Lombardi, Stefania Grimaudo, Paola Dongiovanni, Rosaria Maria Pipitone, Raffaela Rametta, Anna Ludovica Fracanzani, Enrico Mozzi, Antonio Craxı̀ et al. · 2014 · Liver International
Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Hideo Kunimoto, Yushi Sorin, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka et al. · 2016 · Hepatology International
Role of xenobiotics in the induction and progression of fatty liver disease.
J. Klaunig, Xi-Lin Li, Ze-Min Wang · 2018 · Toxicological Research
PSD3 downregulation confers protection against fatty liver disease
Rosellina Margherita Mancina, Kavitha Sasidharan, Anna Lindblom, Ying Wei, Ester Ciociola, Oveis Jamialahmadi, Piero Pingitore, Anne‐Christine Andréasson, Giovanni Pellegrini, Guido Baselli et al. · 2022 · Nature Metabolism
Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics
Huei-Wen Lim, David Bernstein · 2017 · Clinics in Liver Disease
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective
Yasser Mahrous Fouad, Jeffrey Victor Lazarus, Francesco Negro, Markus Peck‐Radosavljevic, Shiv Kumar Sarin, Péter Ferenci, Gamal Esmat, Hasmik Ghazinian, Atsushi Nakajima, Marcelo Silva et al. · 2021 · Alimentary Pharmacology & Therapeutics
Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
Ziqi Zhang, Guang Ji, Meng Li · 2023 · Frontiers in Endocrinology